insights_auto
Why is NXTCL up 5.02%?
Dive Deeperchevron_right
NXTCL:STO
NextCell Pharma AB
SEK 1.00
arrow_upward
+5.02%(+0.048) 1D
Oct 19, 5:29:54 PM GMT+2 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NXTCL...
Open
SEK 0.98
High
SEK 1.01
Low
SEK 0.96
Mkt. cap
126.37M
Avg. vol.
369.66K
Volume
263.88K
52-wk high
SEK 1.78
52-wk low
SEK 0.63
EPS
-SEK 0.45
Shares outstanding
111.39M
No. of employees
21
Open
SEK 0.98
High
SEK 1.01
Low
SEK 0.96
Mkt. cap
126.37M
Avg. vol.
369.66K
Volume
263.88K
52-wk high
SEK 1.78
52-wk low
SEK 0.63
EPS
-SEK 0.45
Shares outstanding
111.39M
No. of employees
21
News stories
From web sources and news partners
Mahoning Matters
·
9 minutes ago
S&P 500, Nasdaq climb as AI-linked stocks recover ahead of earnings
Cryptonews.net
·
7 minutes ago
S&P 500 price prediction on Black Monday’s 39th anniversary
HDFC Sky
·
46 minutes ago
Nasdaq Jumps 259 Points to 26,399 as Intel Surges 5.5% and AI Stocks Rebound After Brutal Selloff
TradingView
·
1 hour ago
The Dow Jones Index Opens 0.08% Lower
Profile
NextCell Pharma AB is a Swedish biopharmaceutical company headquartered in Huddinge, in the Flemingsberg life-science cluster south of Stockholm. The company develops allogeneic mesenchymal stromal cell therapies, with its lead candidate aimed at preserving insulin production in newly diagnosed type 1 diabetes. Alongside its drug development programme, NextCell operates a private umbilical cord stem cell bank and a contract manufacturing and analytical services subsidiary for Advanced Therapy Medicinal Products. NextCell's shares trade on the Nasdaq First North Growth Market in Stockholm under the ticker NXTCL. Wikipedia
About NextCell Pharma AB
CEOMathias Svahn
Employees21
FoundedMar 19, 2014
Headquarters-
SectorBiotechnology
Websitenextcellpharma.com